BioSpace News Archive

Policy

Alnylam Receives Approval of ONPATTRO™ (patisiran) in Europe

ONPATTRO Indicated for the Treatment of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis (hATTR amyloidosis) in Adults with Stage 1 or Stage 2 Polyneuropathy

August 30, 2018
·
13 min read
Pharm Country

Eagle Pharmaceuticals Concludes Enrollment of Second Safety and Efficacy Study at Hajj to Evaluate RYANODEX for Exertional Heat Stroke

Preliminary Analysis: RYANODEX Provides Benefit for Patients

August 30, 2018
·
12 min read
Deals

United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.

United Therapeutics Corporation today announced that it has closed the merger of SteadyMed Ltd. with a subsidiary of United Therapeutics.

August 30, 2018
·
1 min read
Business

Curaleaf Opens Lakeland’s First Medical Marijuana Dispensary

Dispensary Offers FREE Same-Day, Next-Day Delivery Service in Lakeland and surrounding communities

August 30, 2018
·
2 min read
Business

GT Biopharma’s Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration

GT Biopharma Inc. is an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary NK-engager and Bispecific Antibody Drug Conjugate platforms.

August 30, 2018
·
5 min read
Genetown

Haemonetics to Present at Morgan Stanley’s Global Healthcare Conference on September 13, 2018

Haemonetics Corporation announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time.

August 30, 2018
·
1 min read
Genetown

Allergan to Present at the 2018 Wells Fargo Healthcare Conference

Allergan plc today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Wells Fargo Healthcare Conference.

August 30, 2018
·
3 min read
Drug Development

Sangamo Therapeutics Announces Conference Call To Review SB-913 CHAMPIONS Study Data And Participation At Upcoming Investor Conferences

Sangamo Therapeutics, Inc. announced today that management will host a conference call on September 5th at 9:00 a.m. ET to discuss clinical data from the CHAMPIONS Study.

August 30, 2018
·
2 min read
Pharm Country

BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences

BioSpecifics Technologies Corp. today announced that BioSpecifics’ President, Tom Wegman, will present a corporate overview at the following upcoming conferences in September.

August 30, 2018
·
1 min read
Biotech Bay

Kindred Biosciences to Participate in the CL King 16th Annual Best Ideas Conference, Lake Street Capital Markets 2nd Annual Best Ideas Growth Conference and LD Micro San Francisco Summit

Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the LD Micro San Francisco Summit taking place September 4th

August 30, 2018
·
2 min read